4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001012975-17-000932
10% owner acquired 308,412 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Novartis Bioventures Ltd · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-12-13 | Other acquisition : show line 1 in the form | +242,694 | 2,292,257 | I |
| 2017-12-15 | Other acquisition : show line 2 in the form | +65,718 | 2,357,975 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-12-13 | Other disposition : show line 3 in the form Series B Convertible Preferred Stock | −344.94 | 2,414.57 | I |
Loading xslF345X03/edgar.xml…